| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2014 ( Subtotal = -$1,126,264 ) |
| | 2014 | 2013 | PANTHERA BIOPHARMA LLC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701-3919 | HONOLULU | USA | R01AI104586 | IND Enabling Studies for Small Molecule Anthrax Lethal Factor Inhibitors | 001 | 1 | NIH | 1/8/2014 | -$1,126,264 |
|
| Issue Date FY: 2013 ( Subtotal = $634,465 ) |
| | 2013 | 2013 | PANTHERA BIOPHARMA LLC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701-3919 | HONOLULU | USA | R01AI104586 | IND Enabling Studies for Small Molecule Anthrax Lethal Factor Inhibitors | 000 | 1 | NIH | 3/27/2013 | $1,760,729 |
| | 2013 | 2013 | PANTHERA BIOPHARMA LLC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701-3919 | HONOLULU | USA | R01AI104586 | IND Enabling Studies for Small Molecule Anthrax Lethal Factor Inhibitors | 001 | 1 | NIH | 1/8/2014 | -$1,126,264 |
|
| Issue Date FY: 2012 ( Subtotal = $1,140,279 ) |
| | 2012 | 2012 | PANTHERA BIOPHARMA LLC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701-3919 | HONOLULU | USA | U01AI078067 | ANTIDOTES TO ANTHRAX LETHAL FACTOR INTOXICATION | 000 | 5 | NIH | 5/16/2012 | $1,024,280 |
| | 2012 | 2012 | PANTHERA BIOPHARMA LLC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701-3919 | HONOLULU | USA | U01AI078067 | ANTIDOTES TO ANTHRAX LETHAL FACTOR INTOXICATION | 000 | 5 | NIH | 5/16/2012 | $115,999 |
|
| Issue Date FY: 2011 ( Subtotal = $1,206,265 ) |
| | 2011 | 2011 | PANTHERA BIOPHARMA LLC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701 | HONOLULU | USA | U01AI078067 | ANTIDOTES TO ANTHRAX LETHAL FACTOR INTOXICATION | 002 | 4 | NIH | 8/31/2011 | $115,999 |
| | 2011 | 2011 | PANTHERA BIOPHARMA LLC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701 | HONOLULU | USA | U01AI078067 | ANTIDOTES TO ANTHRAX LETHAL FACTOR INTOXICATION | 002 | 4 | NIH | 8/31/2011 | -$115,999 |
| | 2011 | 2011 | PANTHERA BIOPHARMA LLC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701-3919 | HONOLULU | USA | U01AI078067 | ANTIDOTES TO ANTHRAX LETHAL FACTOR INTOXICATION | 001 | 4 | NIH | 8/26/2011 | $115,999 |
| | 2011 | 2011 | PANTHERA BIOPHARMA LLC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701-3919 | HONOLULU | USA | U01AI078067 | ANTIDOTES TO ANTHRAX LETHAL FACTOR INTOXICATION | 000 | 4 | NIH | 6/6/2011 | $1,090,266 |
|
| Issue Date FY: 2010 ( Subtotal = $1,057,909 ) |
| | 2010 | 2010 | PANTHERA BIOPHARMA LLC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701-3919 | HONOLULU | USA | U01AI078067 | ANTIDOTES TO ANTHRAX LETHAL FACTOR INTOXICATION | 000 | 3 | NIH | 5/3/2010 | $1,057,909 |
| | 2010 | 2009 | PANTHERA BIOPHARMA LLC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701 | HONOLULU | USA | R44AI052587 | INHIBITORS OF ANTHRAX LETHAL FACTOR METALLOPROTEINASE | 000 | 8 | NIH | 12/10/2009 | $0 |
|
| Issue Date FY: 2009 ( Subtotal = $2,450,374 ) |
| | 2009 | 2009 | PANTHERA BIOPHARMA LLC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701-3919 | HONOLULU | USA | R43AI079966 | DISCOVERY OF BROAD SPECTRUM DENGUE VIRUS PROTEINASE INHIBITORS | 001 | 2 | NIH | 6/23/2009 | $299,960 |
| | 2009 | 2009 | PANTHERA BIOPHARMA LLC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701-3919 | HONOLULU | USA | U01AI078067 | ANTIDOTES TO ANTHRAX LETHAL FACTOR INTOXICATION | 000 | 2 | NIH | 4/21/2009 | $1,067,549 |
| | 2009 | 2009 | PANTHERA BIOPHARMA LLC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701-3919 | HONOLULU | USA | R44AI052587 | INHIBITORS OF ANTHRAX LETHAL FACTOR METALLOPROTEINASE | 000 | 7 | NIH | 3/10/2009 | $191,700 |
| | 2009 | 2009 | PANTHERA BIOPHARMA LLC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701-3919 | HONOLULU | USA | R44AI052587 | INHIBITORS OF ANTHRAX LETHAL FACTOR METALLOPROTEINASE | 001 | 8 | NIH | 8/21/2009 | $891,165 |
| | 2009 | 2008 | PANTHERA BIOPHARMA LLC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701 | HONOLULU | USA | R43AI079966 | DISCOVERY OF BROAD SPECTRUM DENGUE VIRUS PROTEINASE INHIBITORS | 000 | 1 | NIH | 11/14/2008 | $0 |
| | 2009 | 2007 | PANTHERA BIOPHARMA LLC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701 | HONOLULU | USA | R43AI069584 | DISCOVERY OF WEST NILE VIRUS PROTEASE INHIBITORS | 000 | 3 | NIH | 11/14/2008 | $0 |
|
| Issue Date FY: 2008 ( Subtotal = $2,489,261 ) |
| | 2008 | 2008 | PANTHERA BIOPHARMA LLC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701 | HONOLULU | USA | U01AI078067 | ANTIDOTES TO ANTHRAX LETHAL FACTOR INTOXICATION | 000 | 1 | NIH | 4/28/2008 | $830,000 |
| | 2008 | 2008 | PANTHERA BIOPHARMA LLC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701 | HONOLULU | USA | R43AI066616 | DEVELOPMENT OF A RECOMBINANT SUBUNIT EBOLA VACCINE | 000 | 2 | NIH | 5/12/2008 | $477,131 |
| | 2008 | 2008 | PANTHERA BIOPHARMA LLC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701 | HONOLULU | USA | R44AI052587 | INHIBITORS OF ANTHRAX LETHAL FACTOR METALLOPROTEINASE | 000 | 7 | NIH | 5/21/2008 | $882,133 |
| | 2008 | 2008 | PANTHERA BIOPHARMA LLC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701 | HONOLULU | USA | R43AI079966 | DISCOVERY OF BROAD SPECTRUM DENGUE VIRUS PROTEINASE INHIBITORS | 000 | 1 | NIH | 6/10/2008 | $299,997 |
|
| Issue Date FY: 2007 ( Subtotal = $2,687,114 ) |
| | 2007 | 2007 | PANTHERA BIOPHARMA LLC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701 | HONOLULU | USA | R44AI052587 | INHIBITORS OF ANTHRAX LETHAL FACTOR METALLOPROTEINASE | 000 | 6 | NIH | 6/4/2007 | $899,971 |
| | 2007 | 2007 | PANTHERA BIOPHARMA LLC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701 | HONOLULU | USA | R43AI066616 | DEVELOPMENT OF A RECOMBINANT SUBUNIT EBOLA VACCINE | 000 | 1 | NIH | 6/14/2007 | $479,882 |
| | 2007 | 2007 | PANTHERA BIOPHARMA LLC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701 | HONOLULU | USA | R43AI064987 | STRUCTURE BASED DESIGN OF DENGUE VIRUS FUSION INHIBITORS | 000 | 3 | NIH | 4/4/2007 | $297,685 |
| | 2007 | 2007 | PANTHERA BIOPHARMA LLC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701 | HONOLULU | USA | R43AI069584 | DISCOVERY OF WEST NILE VIRUS PROTEASE INHIBITORS | 000 | 3 | NIH | 6/7/2007 | $499,989 |
| | 2007 | 2007 | PANTHERA BIOPHARMA LLC | 99-193 AIEA HEIGHTS DRIVE | AIEA | HI | 96701 | HONOLULU | USA | R43AI069637 | OPTIMIZATION OF SMALL MOLECULE BOTULINUM NEUROTOXIN INHIBITORS | 000 | 3 | NIH | 5/8/2007 | $509,587 |
|
|
